MICHAEL SEROPYAN: Open Payments
NPI 1386163053 · HALLANDALE BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 25 payments from 11 companies in 2025. Trend: 2023 $1,170 · 2024 $939 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $238 |
| Otsuka America Pharmaceutical, Inc. | 3 | $180 |
| Teva Pharmaceuticals USA, Inc. | 2 | $152 |
| Lundbeck LLC | 4 | $107 |
| Neurocrine BioSciences, Inc. | 3 | $93 |
| Almatica Pharma LLC | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Indivior Inc. | 1 | $19 |
Products named: REXULTI, VRAYLAR, AUSTEDO XR, INGREZZA, LOREEV XR, INVEGA SUSTENNA, Auvelity, COBENFY.
Industry payments across FL — which companies pay providers there.
